We report a multi-omic resource generated by applying quantitative trait locus (xQTL) analyses to RNA sequence, DNA methylation and histone acetylation data from the dorsolateral prefrontal cortex of 411 older adults who have all three data types. We identify SNPs significantly associated with gene expression, DNA methylation and histone modification levels. Many of these SNPs influence multiple molecular features, and we demonstrate that SNP effects on RNA expression are fully mediated by epigenetic features in 9% of these loci. Further, we illustrate the utility of our new resource, xQTL Serve, by using it to prioritize the cell type(s) most affected by an xQTL. We also reanalyze published genome wide association studies using an xQTL-weighted analysis approach and identify 18 new schizophrenia and 2 new bipolar susceptibility variants, which is more than double the number of loci that can be discovered with a larger blood-based expression eQTL resource.
Genome wide association studies (GWAS) have identified thousands of SNPs that are associated with various human diseases 1 . However, most identified SNPs fall in the noncoding regions of the genome 2 . Connecting these regulatory changes to specific genes or to molecular pathways that may be implicated in human diseases is not straightforward. Suggestive evidence indicates that many more such SNPs exist, but they are difficult to detect due to their typically small effect sizes and the challenge of multiple-testing burden in genome-wide assessment of common genetic variation 3 .
Expression quantitative trait locus (eQTL) analyses [4] [5] [6] have been very useful in understanding the functional consequences of traitand disease-associated variants and in identifying genes that are likely to be affected by a risk allele. Recently, QTL analyses have been extended to other molecular phenotypes, such as DNA methylation (mQTL) 7, 8 and histone modification (haQTL) 9 . Overall, SNPs associated with molecular phenotypes (collectively, xQTLs) are over-represented among SNPs that are linked to various traits and diseases 6, 10 , and previous studies have used eQTL hits to prioritize associations in GWAS, leading to improved detection sensitivity [11] [12] [13] . While a few data sets exist for brain tissue, large data sets measuring all three of these epigenomic and transcriptomic features have only recently been generated from the same brain region of each individual.
Here we present a Resource for the neuroscience community by performing xQTL analyses on a multi-omic data set that consists of RNA sequence (RNA-seq), DNA methylation and histone acetylation by chromatin immunoprecipitation and sequencing (H3K9Ac ChIP-seq) data derived from the dorsolateral prefrontal cortex (DLPFC) of up to 494 subjects (411 subjects having all three data types and genotypes available). Samples were collected at autopsy from participants of the Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP), which are two longitudinal studies of aging designed by the same group of investigators. These studies share the same sample and data collection procedures, which facilitate joint analyses 14, 15 . At its heart, the Resource presents a list of SNPs associated with cortical gene expression, DNA methylation and/or histone modification levels that reflects the impact of genetic variation on the transcriptome and epigenome of aging brains. While our xQTLs replicated well in independent brain-and blood-derived QTL resources, a notable portion of xQTLs is specific to genes that are expressed only in older brains. Also, many SNPs influence multiple molecular features, with a small number having their impacts on gene expression mediated through epigenetics. Further, we apply a computational approach to prioritize the cell types that may be driving the tissue-level effect, a critical piece of information for designing follow-up molecular experiments in which an in vitro or in vivo target cell type needs to be selected. Finally, we illustrate the efficacy of an 'xQTL-weighted GWAS' approach that leverages our xQTL resource. We show that this approach increases the statistical power of GWAS, resulting in the detection of a number of new susceptibility variants for several diseases. All data used in this study are available from http://www.radc.rush.edu/, and the xQTL results and analysis scripts can be accessed through our online portal, xQTL Serve, at http://mostafavilab.stat.ubc.ca/xQTLServe/. Figure 1 Overview of xQTL analysis. (a) Graphical summary of our data and analyses. We first associate genetic variation with each data type separately to establish our xQTL reference. We then use these xQTLs to assess whether a given SNP influences more than one data type, whether epigenomic features mediate the effects of SNPs on gene expression, and whether our xQTLs can be leveraged using a weighted GWAS (wGWAS) analysis approach to discover new susceptibility loci. (b) −log 10 P-value of Spearman's correlation between SNPs and DNA methylation (mQTL), histone acetylation (haQTL) and gene expression (eQTL) vs. the SNPs' physical positions in the genome. Each dot represents the strongest association within a cis window for each SNP. (c) Zoomed-in Manhattan plot of chromosome 18 to illustrate P-value distribution of xQTLs at a higher resolution.
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We employed Spearman's rank correlation to estimate the association strength between alleles of each SNP and gene expression (n = 494), DNA methylation (n = 468) and histone acetylation levels (n = 433). We refer to the measurement unit of each molecular phenotype data as a feature and a significant association between a SNP and a feature as an xQTL (that is, an xQTL is a SNP-feature pair). Based on the results of prior studies, we performed cis xQTL analysis between SNPs and each feature by defining a window of 1 Mb for eQTL analysis and haQTL analysis and a window of 5 kb for mQTL analysis 21, 22 . The 1-Mb window for haQTL analysis was motivated by the possibility that SNPs in enhancer regions, which are far away, can indeed impact gene regulation through interaction with promoter regions (for example, chromatin looping). The much smaller window for the mQTL analysis was selected since the majority of cis mQTLs with the strongest correlation lie within a window of this size 22 . Also, the smaller window size helps reduce the multiple-testing burden, given the much larger number of DNA methylation features.
Using a Bonferroni corrected P-value threshold (α FWER = 0.05, two-tailed), we found 3,388 genes associated with eQTL SNPs (P < 8 × 10 −10 ), 56,973 CG dinucleotides linked to mQTL SNPs (P < 5 × 10 −9 ) and 1,681 H3K9Ac peaks influenced by haQTL SNPs (P < 4 × 10 −10 ) (Fig. 1b,c and Table 1) . Among the eQTL genes, 133 of them correspond to long intergenic noncoding RNAs (lincRNAs), out of a total of 391 lincRNAs tested in the eQTL analysis. The complete lists of eQTLs, mQTLs and haQTLs are provided through the xQTL Serve webpage: http://mostafavilab.stat.ubc.ca/xQTLServe/.
Replication and cross-tissue comparisons
We evaluated the extent to which our xQTLs replicate brain eQTLs and mQTLs found in prior studies. We focused on eQTL and mQTL replication since relevant large-sample data sets are only available for these two xQTL types. Specifically, we assessed the replication rate of brain eQTLs discovered in the CommonMind 23 and Braineac 24 studies, and brain mQTLs in a fetal brain study 8 , in our data set using the π 1 statistic 25 , which estimates the proportion of these eQTLs or mQTLs that are also significant in our data set. π 1 values of the eQTLs are 0.91 and 0.56 for CommonMind and Braineac, respectively, and π 1 of mQTLs is 0.87 for the fetal brain study. All of these results are greater than their respective empirical null mean of 0.11 and 0.33 for eQTLs and mQTLs, respectively (P < 0.0001, one-tailed; see Online Methods). The lower replication rate of Braineac eQTLs compared to CommonMind eQTLs could be due to its smaller sample size. Also, the Braineac eQTLs were based on false discovery rate (FDR) correction whereas CommonMind eQTLs were defined using Bonferroni correction, and stronger associations captured by more stringent correction are more likely to replicate 26 . We also assessed the replication rate of our eQTLs in the CommonMind data and estimated a similar replication rate (π 1 = 0.90). For the mQTL replication analysis, we explored restricting our mQTL analysis to a 100-kb window and observed similar replication rate (π 1 = 0.87) on the fetal brain mQTLs 8 , which suggests a 5-kb window already captures most of the stronger associations between SNP and DNA methylation.
For assessing cross-tissue replication, we used a large whole-blood eQTL data set from the DGN study 26 and two smaller eQTL data sets from the Immune Variation (ImmVar) study 27 that consist of monocyte and T cell data. π 1 values of these eQTLs in our data set are 0.63 (whole blood), 0.61 (monocytes) and 0.67 (T cells), which are greater than their empirical null mean of 0.10 (P < 0.0001 for all three data sets, one-tailed). Thus, a large proportion of blood eQTLs are present in our brain data. We also assessed the replication rate of our brain-derived eQTLs in the whole-blood DGN data set ( Fig. 2a,b) . When we considered SNP-gene pairs that could be tested in both studies, we observed a replication rate of 0.83 ( Fig. 2c) , which is greater than its empirical null mean of 0.30 (P < 0.0001, one-tailed). This higher replication rate may be due to the higher statistical power of the DGN study and the fact that cortical tissue consists of a large variety of cell types, which in aggregate express a large proportion of the transcriptome. Since blood contains a mixture of cell types, including immune cells, that share characteristics with those in brain, we further assessed the replication rate on three more tissues, namely subcutaneous adipose, visceral adipose and liver tissues from the GTEx study 28 . The replication rates were 0.51, 0.38 and 0.20, respectively, which are indeed lower than that of blood. Additional replication results for different tissues, window sizes and xQTL types are provided in Supplementary Table 3 .
An important question to answer with our data is whether and which of the detected xQTLs are brain-specific. However, without tissue samples from the same individuals, distinguishing between subject-specific and tissue-specific effects is not possible. Nonetheless, based on the sparsity of 'population-specific' eQTLs 27 and a lower replication rate of eQTLs in blood compared to brain, a notable fraction of our eQTLs are likely tissue-specific. For example, when we considered only eQTLs that consist of the top SNP for each gene, we found that, of the 2,416 eQTLs discovered in our cortical tissue study that are testable in the whole-blood data set 26 , 433 eQTLs (18%) had an unadjusted P > 0.05, indicating that this subset of brain eQTLs is unlikely to be present in blood ( Fig. 2b) . As an example, NLRP1 RNA is expressed in both brain and blood (whole blood, monocytes and T cells), but its expression is associated only with brain-specific eQTL SNPs (Fig. 2d) . NLRP1 is a member of the inflammasome complex that is implicated in inflammatory response in both immune cells (in particular myeloid cells) and brain 29 . Notably, a few small-scale studies have linked polymorphisms in this gene with amyloid-β secretion and Alzheimer's disease 30 . In addition to the 2,416 eQTLs that were testable in both brain and blood, we identified 809 eQTL target genes from our brain eQTL analysis that were absent from the DGN blood eQTL analysis because these genes were not expressed in blood. As expected, this set of 809 brain-specific eQTL genes was enriched for brain-relevant functions (gene set enrichment analysis, FDR < 0.05, two-tailed) such as "neuronal system", "potassium channel components" and "neurotransmitter receptor binding."
Overall, the high cross-sample and cross-tissue replication rates suggest that a large number of SNPs that influence molecular phenotypes are shared across contexts. The degree of overlap between brain and blood eQTLs is high, with a π 1 of ~0.8. Nevertheless, R E S O U R C E our results suggest that some eQTLs are tissue-specific, and more tissue-specific effects would likely emerge from analyses of purified cell populations.
Genetic architecture of xQTL SNPs and sharing across molecular phenotypes
We used epigenomic annotations derived by applying ChromHMM 31 to DLPFC tissue data to estimate the log odds of an xQTL SNP belonging to one of 15 chromatin states in comparison to all non-xQTL SNPs near our molecular features-that is, within 1-Mb, 5-kb and 1-Mb windows for eQTL, mQTL and haQTL analyses, respectively. eQTL SNPs were enriched mainly in promoters and transcribed regions ( Fig. 3a) , conforming to our understanding of how SNPs at transcription factor binding sites can affect protein-DNA interactions 32 and how SNPs in transcribed regions are known to affect mRNA processing and turnover 33 . haQTL SNPs were also largely enriched in promoter and transcribed regions, consistent with the role of H3K9Ac in transcriptional activation 34 . By contrast, mQTL SNPs were mainly enriched in bivalent regions (promoters and enhancers) and Polycomb-repressed regions, which matches previous findings that a large portion of mQTL SNPs resides in chromatin regions that are developmentally regulated 22 . Also, suppressed gene expression in Polycomb-repressed regions might partly explain why eQTL and haQTL SNPs derived from adult samples are scarce in these regions.
Notably, xQTL SNPs that are shared across all three molecular phenotypes were mainly enriched close to the transcription start site (TSS), as well as in the 5′ and 3′ transcribed regions. With respect to transcribed sequences, we saw enrichment for all types of xQTLs in exons relative to introns ( Fig. 3b) , with this trend being most striking for mQTLs. To quantify the degree to which an xQTL SNP influences more than one molecular phenotype, we first identified the list of xQTL SNPs for a 'discovery' phenotype and then estimated the π 1 statistics of the SNP-feature associations for a 'test' phenotype that share the same xQTL SNPs. Since an xQTL SNP might be tested for association with multiple cis features-for example, an mQTL SNP was, on average, tested for association with 18 gene expression levels-we needed to decide which SNP-feature associations to include in the π 1 estimation (Online Methods). In particular, we examined the distance between a discovery SNP and a test feature, and we found this distance to be a prime determinant of cross-phenotype sharing. For example, the most strongly associated eQTL gene for each mQTL SNP is often the gene closest to the mQTL SNP ( Fig. 3c and Supplementary Fig. 5 ). On the basis of this observation, we estimated π 1 to be 0.41-0.63 when considering only the closest feature to each xQTL SNP ( Fig. 3d) . Also, we examined the effect of window size by restricting the haQTL analyses Cross-tissue replication analysis. (a) Scatter plot of −log 10 P-values of associations between the lead brain eQTL SNPs and their associated genes in brain and blood. The dashed red lines denote the significance threshold (α FWER = 0.05 with Bonferroni correction). (b) −log 10 P-value distribution of eQTLs that appear to be brain specific (pink and purple pink; the latter are specific to NLRP1) and those that appear to be non-tissue specific (blue). (c) Distribution of P-values from the DGN study restricted to brain eQTLs. Estimated replication rate (π 1 statistic) between blood and brain eQTLs is 0.83. (d) eQTL P-values at NLRP1 locus. Each dot represents one SNP tested in either brain (ROSMAP) or blood (DGN). The x axis corresponds to the distance between each assessed cis SNP and NLRP1's TSS, and the y axis corresponds to −log 10 P-values for association between SNPs and NLRP1 expression. The linkage disequilibrium between the lead SNP in blood and brain is r 2 < 0.1.
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to 2-kb, 40-kb and 100-kb windows, as well as changing the eQTL and mQTL analysis window to 100 kb, and we found negligible differences in our estimates of xQTL sharing (Supplementary Table 4 ).
The availability of multi-omic data from the same individuals enabled us to go beyond 'overlap analyses' (Fig. 4a) and to investigate the cascading effect of genetic variation through the measured regulatory genomics layers. Specifically, we investigated whether the effect of a regulatory cis xQTL SNP is mechanistically mediated through its impact on epigenetic modification or gene expression using the casual inference test 35 . This analysis was performed on 10,897 xQTL SNPs (influencing 629 genes as based on the eQTL analysis) that were associated with all three molecular phenotypes, as only such SNPs satisfy the precondition for mediation analysis. With this analysis, we distinguished among three models for propagation of information from genetic variation: (i) independent effects of a SNP on cis gene expression and the cis epigenetic landscape (independent model), (ii) a propagation path from SNP to gene expression via epigenetic modifications (epigenetic mediation model), or (iii) a propagation path from SNP to the epigenome (namely DNA methylation) via gene expression (transcription mediation model) ( Fig. 4b) .
Using Bonferroni correction with the casual inference test (n = 411, two-tailed), 9% of the association sets conformed to the epigenetic mediation model, 3% conformed to the transcription mediation model, 85% conformed to the independent model and the remaining 3% could not be classified ( Fig. 4c and Supplementary Table 5 ).
As an example, an xQTL SNP (rs13015714) associated with celiac disease (GWAS P < 10 −8 ) was found to affect IL1RL1 gene expression (P < 10 −11 ), DNA methylation (P < 10 −30 ) and histone modification (P < 10 −12 ), but the impact of this SNP on gene expression appeared to be fully mediated by epigenetic modifications (Fig. 4d,e ), and thus this SNP conforms to the epigenetic mediation model. We also tested whether GWAS SNPs (downloaded from the GWAS catalog 1 ) are preferentially enriched for any of these models but did not find any model-specific enrichment.
A large fraction of the shared xQTL SNPs appear to affect gene expression directly. This result could be explained by (i) epigenetic modification playing a passive role 21 whereby gene expression in fact lies upstream of epigenetic modification (3% based on the transcription mediation model), (ii) regulation of gene expression being dependent on a more complex combination of epigenetic marks that were not measured in our subjects, and (iii) artifactual decorrelation between the expression and epigenomic features due to technical or other factors. Thus, we should interpret the detected mediation as only a subset of true mediation-that is, these may be the most robust subset of mediation events. Further work and more data may be needed to assess this issue more comprehensively. Indeed, when we separately included only DNA methylation or histone modification in the model, we identified a smaller subset of association sets for which an effect on gene expression was fully explained by the epigenetic features: 3% for DNA methylation and 6% for histone modification. Thus, a complementary (nonredundant) combination of DNA methylation and histone acetylation seems to be required to capture the mediation effect, and adding other nonredundant epigenetic features would likely further enhance detection of this type of functional propagation.
Enrichment of disease susceptibility SNPs among xQTL SNPs
Studies have shown that SNPs associated with eQTLs are more likely to influence complex traits and disease susceptibility 6, 10 . Here we provide further support for this observation for eQTLs, mQTLs and haQTLs by performing an enrichment analysis on reported P-values of 16 GWAS data sets, including large-scale GWAS meta-analyses of Alzheimer's disease 36 , schizophrenia 37 , and type II diabetes 38 (Online Methods). Enrichment was assessed using stratified linkage disequilibrium score regression (LDSR) 39 . For all 12 GWAS studies (out of 16) with a minimum of 20,000 samples tested ( Fig. 5a and Supplementary Table 6 ), we observed significant enrichment for the xQTL SNPs. We also repeated this analysis using a more stringent background model, wherein we considered enrichment of our xQTLs against a background set of SNPs falling in "generic" annotation categories as provided in the LDSR software 39 . Again, significant enrichment, albeit with lower effect size, was observed for many of the GWAS studies ( Fig. 5a and Supplementary Table 6 ). Next we hypothesized that SNPs shared between xQTL types, which affect multiple molecular phenotypes, are more likely to affect downstream processes and could constitute a list of 'high confidence' functional SNPs. We therefore compared all xQTL SNPs shared across at least two molecular traits against those xQTLs only found for one molecular trait. We indeed observed enrichment for the shared xQTLs, but their enrichment was not always higher than the background xQTL SNPs-that is, the level of enrichment was somewhat trait dependent ( Supplementary Table 6 ). To test the robustness of the results to window size, we repeated the analysis with 100-kb windows for all three xQTL types (Supplementary Table 7 ). The overall trend remained the same, with slightly higher enrichment observed. The enrichment results are reassuring, and, as we describe later, we can use our list of xQTL SNPs to enhance susceptibility locus discovery in GWAS studies. Investigators can also confidently use our xQTL lists to annotate GWAS SNPs related to the brain or nervous system, which will accelerate the transition to functional studies. For example, we used our eQTLs to map the 21 SNPs (and correlated SNPs in linkage disequilibrium with r 2 > 0.8) reported in the IGAP Alzheimer's disease GWAS and identified four candidate Alzheimer's disease-associated genes that are absent from the reported gene list defined by proximity 36 (MADD, MTCH2, PILRA and POLR2E). The TSS of these eQTL-mapped genes were >100 kb, on average, from their respective Alzheimer's disease-associated SNPs. MTCH2, PILRA and POLR2E have also been found in recent eQTL mapping studies 40 , demonstrating the robustness of our results. MADD has not been previously reported in this context but is a good candidate given that its expression correlates with neuronal cell death in Alzheimer's disease 41 and that it has also been reported to modulate Alzheimer's disease-related tau toxicity in a Drosophila model 42 .
Accelerating the transition to functional studies in specific cell types Selection of the relevant cell type to target for in vitro or in vivo followup functional studies is challenging because our xQTLs, like those identified in many other studies, rely on tissue profiles generated from a complex mixture of cell types. To help prioritize cell types for such follow-up efforts, we repeated the analyses relating each SNP to a given molecular feature but also included a variable that estimates the proportion of a cell type in the profiled tissue and an interaction term to identify those SNPs whose effects depend on the proportion of a target cell (Online Methods). This approach was recently validated using whole-blood data 43 .
Using eQTL results as an example (n = 494, two-tailed), we examined the potential specificity of each lead eQTL SNP for five cell types that are abundant in the cortex: neurons, microglia, astrocytes, oligodendrocytes and endothelial cells. We found that assignment to a single cell type was ambiguous for most eQTLs (P-values available at http://mostafavilab.stat.ubc.ca/xQTLServe). With a more lenient discovery strategy in which we thresholded the interaction term at FDR < 0.2, we found putative cell-type-specific effects in neurons (n = 13) and microglia (n = 22; Fig. 5b ). In fact, in a minority of cases, our analysis returned an unambiguous cell type for the lead eQTL. For example, at FDR < 0.05, we identified six significant cellspecific eQTLs (one astrocytic, three microglial and one neuronal). An example is presented in Figure 5c . The CPVL locus harbors an eQTL effect (rs11971828) that is stronger in microglial cells. Even though only a small number of cell-specific eQTLs were identified with multiple-testing correction, our results can still be useful in prioritizing cell types for follow-up experiments based on the observation that suggestive cell-type-specific eQTL genes show clear cell type preferences. Many of these top cell-specific eQTL genes tend to conform to the expected function of the implicated cell. For example, the MGMT locus harbors an eQTL that ranks among the top three for oligodendrocyte specificity (P = 1.5 × 10 −4 ). MGMT is known to function in oligodendrocytes, and its mutations are associated with oligodendrogliomas. These cell-specific results are intriguing but require molecular validation using purified cell populations from the cortex with matched genotypes to be confirmed.
xQTL-weighted GWAS for gene discovery efforts
Our large compendium of brain xQTLs can also be leveraged to accelerate gene discovery by boosting statistical power in GWAS. The simplest way of using our xQTL SNP list would be to restrict association analysis to our xQTL SNPs. However, such a strategy would miss other relevant SNPs that are not in our list (or were not tested in the cis xQTL analysis). Thus, we opted to use a weighted Bonferroni procedure 44 , which permits all SNPs to be analyzed but weights their P-values by their potential phenotypic relevance. We refer to this approach as an "xQTL-weighted GWAS." Provided that the weights are non-negative and average to 1, strong control on family-wise error rate is guaranteed 44 . We employed a binary weighting scheme, in which P-values of xQTL SNPs were divided by w 1 and all other SNPs were divided by w 0 with s = w 1 /w 0 > 1 (see Online Methods for s selection). Consistent with the standard GWAS convention, significance was declared at P < 5 × 10 −8 . To not over-count the number of significant hits due to correlations between SNPs, we applied PLINK 45 1.9 on the 1000 Genomes phase 1 data 19 to remove SNPs among the significant hits that are in linkage disequilibrium with one another (r 2 < 0.2).
We compared five approaches: (i) no weighting, (ii) weighting xQTL SNPs found for any of the molecular phenotypes, (iii) weighting SNPs within predefined windows from the molecular features (1 Mb, 5 kb and 1 Mb for eQTL, mQTL and haQTL analyses, respectively) to account for distance bias, (iv) weighting generic functional SNP in the LDSR baseline model 39 , and (v) weighting xQTL SNPs that are shared across any of the molecular phenotypes. Over the 19 GWAS data sets (Online Methods), weighting xQTL SNPs resulted in an equal or greater number of GWAS hits than no weighting, except for inflammatory bowel disease ( Supplementary Table 8 ). For 8 of the 19 studies, the xQTL-weighted GWAS approach found at least two new independent loci ( Supplementary Table 8 ). By contrast, weighting SNPs within predefined windows from the molecular features, as well as weighting SNPs in the LDSR baseline model, resulted in little change in detection sensitivity. Of note, the gain in sensitivity was not always the highest when we weighted the shared xQTL SNPs. Also, compared to weighting the DGN eQTL SNPs, weighting the union of all xQTL SNPs found in this study identified more additional independent susceptibility SNPs for a majority of the tested GWAS data sets, which demonstrates that additional signals are captured by mQTL and haQTL SNPs. In particular, weighting the xQTL SNPs found 22, 18 and 9 additional independent SNPs for schizophrenia, height and inflammatory bowel disease, respectively, compared to no weighting. In contrast, weighting the DGN eQTL SNPs found only 9, 3 and 2 additional independent SNPs. In fact, weighting just the eQTL SNPs in our data set identified 17 additional independent SNPs for schizophrenia, which illustrates the presence of eQTLs in our data that are enriched in brain diseases and not observed in blood.
Among the brain diseases that we examined, the largest detection gain was obtained with the schizophrenia data set 37 , where 18 additional loci met genome-wide significance (excluding those near the MHC region) and were not in linkage disequilibrium (r 2 < 0.2) with the reported susceptibility SNPs 37 . Seven of these 18 SNPs were found to be associated with eQTLs (Supplementary Table 8) , including rs57709857, which influences LSM1, a gene previously found in a Han Chinese schizophrenia study 46 . However, the LSM1 locus had not reach genome-wide significance in individuals of European ancestry 47 . The list of eQTL genes also includes PCNX (associated with rs2189806), a gene encoding a member of the Notch signaling pathway that was reported to harbor a de novo copy number variant linked to autism spectrum disorder 48 , and CPEB1 (associated with rs1864699), which was recently implicated in experience-dependent neuronal development and circuit formation 49 (Fig. 5d,e) . Thus, several of our new schizophrenia loci have some face validity, but further replication efforts are required to ensure that these are robust findings. In terms of the percentage increase in detection sensitivity, the largest gain was observed for bipolar disorder 50 , where the standard GWAS approach identified one significant hit whereas the xQTLweighted GWAS identified two additional independent loci.
DISCUSSION
Using one of the largest multi-omic data sets for brain tissue, we generated a list of xQTLs as a Resource for the neuroscience community to further investigate the interplay between the genome, epigenome and transcriptome in disease susceptibility. Our list of xQTLs replicates well in both brain and blood data sets, but it also contains xQTLs that appear unique to the older brain. Notable biological insights drawn from this Resource include significant sharing of xQTL SNPs across the measured molecular phenotypes. Also, the effects of some eQTL SNPs are fully mediated by our two epigenetic features, but further work and more data are needed to comprehensively assess the extent to which epigenomic features mediate eQTL effects. Overall, we create a large new reference with which investigators can functionally annotate their results; enhance their analyses, as illustrated by our xQTL-weighted GWAS approach; and guide functional studies, as in our cell type analysis. This Resource can be easily accessed through our portal, xQTL Serve.
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experimental design and statistical analyses. Details on experimental design and reagents is described below and in the life Sciences Reporting Summary.
No power calculations were performed, but our sample sizes are similar to or larger than those of other brain QTL studies for RNA expression 23, 24 , DNA methylation 8 and ChIP-seq data 51 . Appropriate statistical tests have been specifically chosen for various analyses described below. For instance, we used Spearman's correlation for the xQTL analyses, which does not assume normality and equal variance. For assessing significance of the replication rate, we used the permutation test, which also does not assume normality. For testing genomic enrichment, which involves SNP counts as input, we used log odds. For testing mediation effects, we used the causal inference test, which take P-values from a set of associations. For testing trait and disease enrichment, we used LDSR and weighted GWAS, which take P-values as input.
data acquisition, quality control, and normalization for known technical factors. The ROSMAP study is a longitudinal study in which all participants were healthy at enrollment. The sampled subjects thus represent a relatively random set of older individuals. By the time of death, 58% and 38% of participants were diagnosed with pathological and clinical Alzheimer's disease, respectively (Supplementary Table 1 ). These percentages are consistent with the Alzheimer's disease population prevalence. No randomization in subject selection was performed. For each -omic data type, data generation was attempted on all subjects with available frozen brain samples. The characteristics of the subjects in our analyses are similar to those of the overall ROS and MAP cohorts. A single person performed all of the dissections of the frozen tissues in isolating the gray matter for gene expression, DNA methylation and histone modification data generation to minimize technical variability in sample preparation. The individuals involved in collecting the autopsy samples and processing them during data generation were blinded to the phenotypic characteristics of the subjects.
Genotype data 16 . Genotyping of the ROS and MAP subjects was performed on the Affymetrix Genome-Wide HumanSNP Array6.0 (n = 1,709) and the Illumina OmniQuad Express platform (n = 384). DNA was extracted from whole blood, lymphocytes or frozen brain tissue as previously described 16 . To minimize population admixture, only self-declared non-Hispanic Caucasians were genotyped. At the sample level, samples with genotyping success rate < 95%, discordant genetically inferred and reported gender, or excess inter/intra-heterozygosity were excluded. At the probe level, genotyping data from both platforms were processed with same quality control (QC) metrics: Hardy-Weinberg equilibrium P > 0.001, genotype call rate < 0.95, mishap test < 1 × 10 -9 . QC was performed using version 1.08 of the PLINK software 52 . EIGENSTRAT 53 was used with the default setting to remove population outliers and to generate a genotype covariance matrix. The resultant data sets include 729,463 SNPs for 1,709 individuals (Affymetrix) and 624,668 SNPs for 384 individuals (OmniQuad). Dosages for all SNPs (>35 million) on the 1000 Genomes reference were imputed using version 3.3.2 version of the BEAGLE software 18 (1000 Genomes Project Consortium interim phase I haplotypes, 2011 phase 1b data freeze). Imputed SNPs were filtered based on minor allele frequency (MAF) > 0.01 and imputation INFO score > 0.3, resulting in 7,321,515 SNPs available for analysis.
Gene expression data 54 . Gene expression data were generated using RNA-seq from dorsolateral prefrontal cortex (DLPFC) of 540 individuals, at an average sequence depth of 90 million reads. Detailed description of data generation and processing will be described (S.M., C.G. et al., unpublished data) and is summarized here.
Samples were submitted to the Broad Institute's Genomics Platform for transcriptome analysis following the dUTP protocol with poly(A) selection 55 . All samples were chosen to pass two initial quality filters: RNA integrity (RIN) score > 5 and quantity threshold of 5 µg. They were selected from a larger set of 724 samples. Sequencing was performed on the Illumina HiSeq with 101-bp paired-end reads and achieved coverage of 150 million reads of the first 12 samples. These 12 samples served as a deep coverage reference and included 2 males and 2 females each of unimpaired, mildly cognitively impaired and Alzheimer's disease status (Supplementary Fig. 1) . The remaining samples were sequenced with a target coverage of 50 million reads. The mean coverage for the samples passing QC was 95 million reads (median 90 million reads) (Supplementary Fig. 1) . The libraries were constructed and pooled according to the RIN scores such that similar RIN scores were pooled together (Supplementary Fig. 1) . Varying RIN scores results in a larger spread of insert sizes during library construction and leads to uneven coverage distribution throughout the pool.
RNA-seq data were processed by our parallelized pipeline. This pipeline included trimming the beginning and ending bases from each read, identifying and trimming adaptor sequences from reads, detecting and removing rRNA reads, aligning reads to the reference genome using Bowtie 56 and quantifying transcript expression levels using RSEM 57 . Specifically, RNA-seq reads in FASTQ format were inspected using FASTQC program. Barcode and adaptor contamination and low quality regions (8 bp at the beginning and 7 bp at the end of each fastq read) were trimmed using the FASTX toolkit. To remove rRNA contamination, we aligned trimmed reads to rRNA reference (rRNA genes were downloaded from UCSC genome browser selecting the RepeatMask table) by BWA then extracted only paired unmapped reads for transcriptome alignment. rRNA-depleted reads were then mapped to the transcriptome reference (gencode v14) using the Trinity package with RSEM as the output option. Gene expression FPKM values were estimated using "rsem-calculate-expression" from RSEM.
Samples from 494 individuals were used in the eQTL analysis, which include those that had QCed genotype and passed the expression outlier test 6 (D < 0.9). To quantify the contribution of experimental and other confounding factors to the overall expression profiles, we performed a PCA on log-transformed FPKM values in all samples and computed the correlation between the top ten PCs and experimental factors (Supplementary Fig. 2) . We observed significant correlations between many of these technical and confounding factors and top expression PCs (removal of which is described in the next section). With the log-transformed FPKM data, we used the COMBAT algorithm 58 to account for the effect of batch and linear regression to remove the effects of RIN, postmortem interval (PMI), sequencing depth, study index (ROS sample or MAP sample), genotyping PCs, age at death and sex. Finally, only highly expressed genes were kept (mean expression > 2log 2 (FPKM)), resulting in 13,484 expressed genes for eQTL analysis. This FPKM-based threshold was determined through visual inspection of a histogram of mean expression values to approximately define two expression distributions: (i) no expression or very low expression and (ii) moderate to high expression.
DNA methylation data 17 . DNA methylation data were generated using the 450K Illumina array from DLPFC of 740 individuals. A detailed description of data acquisition and QC is previously published 17 . Briefly, methylation probes that coincided with common polymorphic sites were removed. Initial normalization of CpG probes to account for differences between type I and type II probes was performed using the BMIQ algorithm from the Watermelon package 59 and β-values were extracted for further analysis. The SNM approach 60 was then used to regress out the effects of batch, PMI, sex, age at death and a previously published estimate of proportion of neurons present in each sample 17 . In this study, samples from 468 individuals were analyzed, for whom gene expression data were also available. As described below, this decision was made to enable using gene expression data to estimate the proportions of the five main brain cell types. This correction for cell type proportions was done in addition to the regression approach for removing the effect of generic neuronal proportions based on DNAm marks 17 .
Histone modification data 54 . Histone modification data were generated using H3K9Ac ChIP-seq from DLPFC of 714 individuals. Single-end reads were aligned by the BWA algorithm 61 , and peaks were detected in each sample separately using the MACS2 algorithm 62 (using the broad peak option and a q cutoff of 0.001). A series of QC steps was employed to identify and remove low quality reads, and samples that did not reach (i) ≥15 × 10 6 unique reads, (ii) nonredundant fraction ≥ 0.3, (iii) cross-correlation ≥ 0.03, (iv) fraction of reads in peaks ≥ 0.05 and (v) ≥6,000 peaks were removed. Cross-correlation was defined as the maximum Pearson's correlation between the read coverage on the negative and positive strand after binning reads into 10-bp bins 63 . Cross-correlation was calculated after shifting the reads on the negative strand by s base pairs for s = 0, 10, 20, …, 1,000, and the maximum cross-correlation was reported. In total, 669 samples passed quality control (Supplementary Fig. 3) .
H3K9Ac domains were defined by calculating all genomic regions that were detected as a peak in at least 100 of the 669 samples (15%). Regions within 100 bp of each other were merged and very small regions of less than 100 bp were removed. Reads were then extended toward the 3′ end to the fragment size of the respective sample. The fragment size was estimated by the shift s max that maximized the cross-correlation (mean s max = 271 bp). Finally, the number of extended reads in each H3K9Ac region was determined for each sample. Only uniquely mapped distinct reads were considered.
Quantified histone acetylation data were quantile normalized to account for variability in sequencing depth across individuals. Samples from 433 individuals for which gene expression data were available were used in our analysis.
Additional removal of known and hidden confounding factors. In addition to the data-specific QC and normalization described above, the effects of ancestry, cell type composition and 'hidden factors' were regressed out from the gene expression, DNA methylation and histone acetylation data. Variables representing ancestry were defined using the top three principal components of the genotype data. Cell type composition was estimated using gene expression levels of markers of main brain cell types: neurons (ENO2), oligodendrocytes (OLIG2, MBP, CNP), astrocytes (GFAP), microglia (CD68) and endothelial cells (CD34). Hidden confounding factors included top N PCs from the gene expression, DNA methylation and histone modification data (separately). PCA-based hidden factors typically capture variation in cell type proportions across individuals and other unmeasured confounding factors 20, 64 . Following previous studies 26 , for each molecular phenotype data, we varied N from 1 to 30 at a log 10 scale and defined 'optimal' N as the value at which the number of significant hits in chromosome 18 saturated (Supplementary Fig. 4) . We chose to assess performance on only chromosome 18 as opposed to all chromosomes to avoid overfitting. The optimal N was found to be approximately 10 for all three data types. xQTl association analysis. Spearman's rank correlation was used to estimate the association strength between the alleles of each SNP and the three molecular phenotypes measured. For eQTL analysis (n = 494), we used SNPs that were up to 1 Mb upstream or downstream of the TSS of each gene. For mQTL analysis (n = 468), we used SNPs that were within 5 kb of each methylation site. For haQTL analysis (n = 433), we used SNPs that were within 1 Mb of each acetylation peak. The window sizes are informed by previous studies 21, 22, 65 . For each xQTL type, we declare an association as significant if its P was less than 0.05 after Bonferroni correction (two-tailed). Bonferroni threshold was determined separately for eQTL (P < 8 × 10 −8 ), mQTL (P < 5 × 10 −9 ) and haQTL (P < 4 × 10 −10 ) analysis based on the number of tested associations.
Replication estimation with π 1 statistic. We performed replication analysis for eQTLs and mQTLs using previous brain-based studies 8, 23, 24, 66 , blood-based studies 26, 27 and the GTEx study 28 to evaluate cross-sample replication and crosstissue replication. Replication rates were estimated using the π 1 statistic 25 , which provides an estimate of the proportion of xQTLs that are significant based on their P-value distribution. Only associations comprising the top SNP for each eQTL gene and each mQTL probe were included in the π 1 estimation, to avoid including many SNPs in linkage disequilibrium with each other in this analysis. For π 1 estimation, we used P-values from this study restricted to the eQTLs and mQTLs found in previous studies. That is, we used an existing reference eQTL or mQTL list and assessed the replication of those reported xQTLs in our data set. When possible, we also estimated π 1 in the other direction. Specifically, we assessed the replication rate of our eQTLs in a large DLPFC data set 23 and a large whole-blood data set 26 . To determine whether the replication rate was higher than chance level (one-tailed), we generated empirical null distributions by computing π 1 for 10 4 random P-value subsets of size m, where m is the number of eQTLs or mQTLs. Only P-values of associations that did not overlap with the eQTLs and mQTLs were used for null estimation. genomic annotations. To examine whether the xQTL SNPs are enriched in specific gene regions, we used genomic annotations from the ChromHMM resource 31 , which comprise 15 categories: (1) active TSS (TssA), (2) flanking active TSS (TssAFlnk), (3) transcription at gene 5′ and 3′ (TxFlnk), (4) strong transcription (Tx), (5) weak transcription (TxWk), (6) genic enhancers (EnhG), (7) enhancers (Enh), (8) zinc finger genes and repeats (ZNF/Rpts), (9) heterochromatin (Het), (10) bivalent/poised TSS (TssBiv), (11) flanking bivalent TSS/ enhancers (BivFlnk) (12) bivalent enhancers (EnhBiv), (13) repressed Polycomb (ReprPC), (14) weak repressed Polycomb (ReprPCWk) and (15) quiescent/low (Quies). We also used the knownGene table (GRCh37/hg19 assembly) provided on the UCSC genome browser website 67 to examine whether the xQTL SNPs are enriched in exons and introns. For each xQTL type, we computed the odds ratio of the xQTL SNPs being in each of the gene regions-that is, within predefined windows from the molecular features (1 Mb, 5 kb and 1 Mb for eQTL, mQTL and haQTL analyses, respectively)-versus all other tested SNPs. We further estimated the probability of observing an xQTL SNP at a certain distance from the TSS of its respective gene(s) by computing the number of xQTL SNPs at different distances away from TSS and dividing that by the number of tested SNPs to account for sampling biases. estimation of xQTl SnP sharing across molecular phenotypes. The π 1 statistic was employed to estimate the sharing of xQTL SNPs across molecular phenotypes. Using sharing between mQTLs and eQTLs as an example, with methylation and gene expression being the discovery and test phenotypes, respectively, we computed π 1 with P-values of the tested SNP-expression associations that consist of mQTL SNPs. This π 1 analysis provides an estimate of the proportion of SNP-expression associations that are significant when we restrict to associations comprising mQTL SNPs: that is, if most mQTL SNPs also drive gene expression, then the corresponding π 1 would be high. Since an mQTL SNP might be tested for association with expression levels of multiple genes, we had to decide which associations to include in the π 1 estimation. A lenient strategy would be to retain only the strongest association for each mQTL SNP, and a more stringent strategy would be to include all tested associations. With the lenient strategy, we estimated a cross-phenotype sharing (π 1 ) of ~0.83-0.97 for different pairs of phenotypes. With the more stringent strategy, we estimated a cross-phenotype sharing (π 1 ) of ~0.1-0.35. For the more stringent strategy, we note that as we decreased the allowable genomic distance between a discovery SNP and a tested feature, which by construction shrinks the coverage of xQTL SNPs, the cross-phenotype sharing increased (Supplementary Fig. 5) .
The lenient strategy likely provides an over-estimate of π 1 , since the retained associations were selected by their strength-that is, the smaller P-values kept. To tighten up our assessment of xQTL SNP sharing while not being overly stringent, we examined the distance between each discovery SNP and test feature, which we found to be a prime determinant of cross-phenotype sharing. For example, the strongest associated eQTL gene for each mQTL SNP is often the gene closest to the mQTL SNP. We also observed similar trends for other cross-phenotype comparisons (results not shown). Based on this observation, we modified our analysis to only consider the closest feature to each xQTL SNP. mediation analysis. We applied causal inference test (CIT) 35 to investigate whether the effect of a regulatory cis eQTL SNP is propagated through its impact on DNA methylation and/or histone modification (causal model), as well as whether the effect of an eQTL SNP on DNA methylation and/or histone modification is mediated through gene expression (reactive model). In brief, for the causal model, applying the CIT involves testing the following four associations: (i) an eQTL SNP is associated with the first PC of its associated histone acetylation peaks and methylation probes (that is, epigenome PC), (ii) this eQTL SNP is associated with expression of a gene, (iii) this eQTL SNP is associated with the epigenome PC conditioned on gene expression, and (iv) this eQTL SNP is independent of gene expression given epigenome PC. Testing the reactive model involves reversing the role of gene expression and epigenome PC. A P-value (twotailed) was assigned to each set of associations using the intersection-union test 35 . Bonferroni correction was applied to account for the number of tested association sets m. We declared an association set as conforming to the causal model (or epigenetic mediation model) if pCausal < 0.05/m and pReact > 0.05/m and conforming to the reactive model (or transcription mediation model) if pCausal > 0.05/m and pReact < 0.05/m. An association set was declared as conforming to the independent model if pCausal > 0.05/m and pReact > 0.05/m. The remaining association sets were considered unclassified. The above analysis (n = 411) was performed on 20,916 association sets for the 10,897 xQTL SNPs that were associated with all three molecular phenotypes. We restricted analysis to these shared xQTL SNPs because only these SNPs would fulfill conditions (i) and (ii). The same analysis was also performed to assess the mediation of the shared xQTL SNPs through DNA methylation and histone acetylation separately. In this analysis, when multiple CpG probes (or acetylation peaks) were associated with a given xQTL SNP, we used their first PC to summarize their combination. 
Initial submission Revised version Final submission
Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design 1. Sample size
Describe how sample size was determined. The sample size is adequate based on numerous previous papers that derive eQTLs and mQTLs. Indeed, using Bonferroni correction, our sample size yielded thousands of significant associations.
Data exclusions
Describe any data exclusions. Except for analyses that require the presence of all three -omic datatypes, no samples were excluded in any of the analyses.
Replication
Describe whether the experimental findings were reliably reproduced.
The xQTLs replicated well in other published datasets.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
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Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
NA
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
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